SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 140 filers reported holding SUTRO BIOPHARMA INC in Q1 2021. The put-call ratio across all filers is 0.23 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $35,568 | -23.5% | 10,250 | +2.5% | 0.00% | – |
| Q2 2023 | $46,500 | +0.6% | 10,000 | 0.0% | 0.00% | – |
| Q1 2023 | $46,200 | -39.8% | 10,000 | +5.3% | 0.00% | – |
| Q4 2022 | $76,760 | +1819.0% | 9,500 | +4650.0% | 0.00% | – |
| Q4 2020 | $4,000 | +100.0% | 200 | 0.0% | 0.00% | – |
| Q3 2020 | $2,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q2 2020 | $2,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q1 2020 | $2,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $39,611,000 | 19.08% |
| Samsara BioCapital, LLC | 1,675,579 | $36,377,000 | 3.66% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 185,000 | $4,016,000 | 2.33% |
| Affinity Asset Advisors, LLC | 200,000 | $4,342,000 | 2.30% |
| Altium Capital Management LP | 276,719 | $6,008,000 | 2.24% |
| FRAZIER MANAGEMENT LLC | 1,001,421 | $21,741,000 | 1.67% |
| BVF INC/IL | 1,854,162 | $40,254,000 | 1.58% |
| Asymmetry Capital Management, L.P. | 157,583 | $3,421,000 | 1.56% |
| Parkman Healthcare Partners LLC | 266,645 | $5,789,000 | 1.48% |
| AJU IB Investment Co., Ltd. | 175,000 | $3,799,000 | 1.44% |